Objective: It has been shown that adults with either long-standing type 1 or type 2 diabetes had lower skeletal muscle strength than non-diabetic adults in cross-sectional studies. The aim of the study was to investigate longitudinal changes of muscle mass and strength in community dwelling older adults with and without type 2 diabetes. Research Design and Methods: We examined leg and arm muscle mass and strength at baseline and three years later in 1,840 older adults aged 70 to 79 years in the Health, Aging and Body Composition Study. Regional muscle mass was measured by dual energy X-ray absoptiometry and muscle strength was measured using isokinetic and isometric dynamometer. Results: Older adults with type 2 diabetes (n, 305) showed greater declines in the leg muscle mass (-0.29 ± 0.03 vs. -0.23 ± 0.01 kg, p<0.05) and strength (-16.5 ± 1.2 vs. -12.4 ± 0.5 Nm, p=0.001) compared with older adults without diabetes. Leg muscle quality, expressed as a maximal strength per unit muscle mass (Nm/kg), also declined more rapidly in older adults with diabetes (-1.6 ± 0.2 vs. -1.2 ± 0.1 Nm/kg, p<0.05). Changes in arm muscle strength and quality were not different between those with and without diabetes. Rapid declines in leg muscle strength and quality were attenuated but remained significant after controlling for demographics, body composition, physical activity, combined chronic diseases, interleukin-6 and tumor necrosis factor-α. Conclusion: In older adults, type 2 diabetes is associated with accelerated loss of leg muscle strength and quality.
In industrialized countries, the major increase in the number of people with diabetes is attributed to the aging of the population (1, 2) . In older adults, diabetes is associated with a two-to threefold increased risk of injurious falls (3) and physical disability (4) (5) (6) (7) (8) . Several factors have been identified as contributors to diabetes-related disability including obesity (4, 5) , coronary heart disease (4, 5, 7), stroke (4), arthritis (4, 5) , depression (7) , and visual impairments (4, 5) . But still a large portion of diabetesdisability relationship is not explained by above factors. Alterations in muscular function in diabetes can be a potential pathway, which have not yet been explored.
Muscle weakness in diabetes has been considered as a rare manifestation associated with severe diabetic neuropathy (9) . However, recent studies using quantitative assessments of muscular function showed that skeletal muscle strength, especially in lower extremity, is generally lower in adults with diabetes than non-diabetic subjects (10) (11) (12) . The Health, Aging, and Body Composition Study (Health ABC) was designed to investigate the impact of changes in body composition and health conditions on age-related physiological and functional status among adults from 70 to 79 years of age. In this cohort, we have reported that older adults with type 2 diabetes had lower skeletal muscle strength and quality (12) . However, it is still unclear whether lower muscle strength in diabetes is a consequence of diabetes or just a coincidence because previous studies were cross-sectional observations. To address this question, we reexamined knee extensor and hand grip strength and body composition three years after initial examination in the Health ABC Study. We hypothesized that older adults with type 2 diabetes would show a greater decline in skeletal muscle strength and quality than older adults without diabetes.
Research Design and Methods

Study population:
The Health ABC Study included well-functioning community-dwelling older adults aged 70 to 79 years. The Health ABC Study was described in detail elsewhere (12) . Among 2,618 participants who had completed baseline assessments for skeletal muscle mass and strength, 1,840 (70.3 %) were reexamined three years later. The reasons for not having followup data were death (n = 146), development of disability and/or institutionalization (n = 302), missed contact (n = 77), withdrawal of the participants (n =11), unable to perform knee strength test (n = 191), and missing data on body composition (n = 51). All participants provided informed consent before participating in the study. The consent forms and study protocols were approved by the institutional review boards at each field center.
Diabetes assessment: Participants were considered as having type 2 diabetes if they had (i) a report of having been diagnosed as diabetes with the onset after age 25 and/or (ii) current use of oral hypoglycemic medications or insulin, or (iii) a fasting plasma glucose concentration ≥ 7.0 mmol/l at baseline. Plasma glucose was measured using an automated glucose oxidase reaction (Vitros 950 analyzer, Johnson and Johnson, Rochester, NY) and a glycated hemoglobin (A1C) was measured by enzymatic method (Bio-Rad, Hercules, CA).
Body composition: Lean mass of the upper and lower extremities as well as the total body were assessed using dual energy x-ray absorptiometry (Hologic QDR 4500, software version 8.21, Bedford, MA). The validity and reproducibility of the body composition data in the Health ABC Study may be found elsewhere (13, 14) . Qualityassurance measures included the use of a body composition phantom for calibration and annual assessment for potential site differences or drift over time.
Strength assessments: Strength was measured using an isokinetic dynamometer (Kin-Com dynamometer, 125 AP, Chattanooga, TN) for knee extension and isometric dynamometer (Jaymar, JLW Instruments, Chicago, IL) for hand grip strength. For knee extension, maximal voluntary concentric isokinetic torque was assessed in Newton-meters (Nm) at angular velocity of 60 o /s. At least three, but no more than six, maximal efforts were allowed to produce three overlying curves and the mean maximal torque was recorded and used for the analysis. The right leg was used unless contraindicated by pain or history of joint replacement. For the validation of knee strength assessments, we performed a reliability study in 63 participants.
The inter-examiner coefficient of variation (CV) was 4.85 % with no significant differences between examiners. The intra-participant CV was 10.68 % and the CV for combined effect of examiner and participant was 11.73%.
Isometric grip strength was assessed for each hand. Participants with severe hand pain or recent surgery were excluded. The vast majority (96 %) who had leg strength testing also had grip strength testing. For these analyses, we used the maximum of the force from two trials for the right upper extremity. A measure of muscle quality (leg specific torque; Nm/kg, arm specific force; kg/kg) was created by taking the ratio of strength to the entire corresponding leg or arm muscle mass in kg measured by DXA.
Other
covariates: Sociodemographic characteristics included age, gender, race, and education. Combined chronic diseases such as coronary heart disease, congestive heart failure, stroke, peripheral artery disease, knee osteoarthritis, depression, and cancer were identified by self report and confirmed by treatment and medication use. Self-reported poor eyesight was considered as impaired vision. Renal insufficiency was defined by serum creatinine greater than 1.5 mg/dl in men, and 1.2 mg/dl in women (15) . Ankle-arm index (AAI) was calculated and subclinical peripheral artery disease was defined by AAI < 0.9. Health-related behaviors including smoking, alcohol drinking, and level of physical activity (kcal/week) were determined by using a standardized questionnaire (16). Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured in duplicate using an untrasensitive enzymelinked immunosorbent assay (R&D Systems, Minneapolis, Minn). The lower limit of detection was less than 0.10 pg/ml for IL-6 and 0.18 pg/ml for TNF-α, with coefficients of variation of 6.3% and 16.0%, respectively.
Statistical
analyses. Baseline characteristics of the cohort are presented separately for those with and without diabetes. Chi-square tests were calculated for categorical variables and a t-test was used for continuous variables to test for any statistical differences between the two groups. Longitudinal changes of muscle strength and quality were calculated in both absolute terms and relative terms (percent change from baseline). Differences between older adults with and without diabetes were assessed by general linear models controlling for sex, race, age, and clinic site (model 1). Additional adjustments were made for body mass index, baseline strength or quality, changes in muscle mass, and physical activity (model 2), plus combined chronic diseases, and diabetes related complications (model 3), and inflammatory cytokines (log transformed IL-6 and TNF-α in model 4). A p-value of <0.05 was accepted as statistically significant. All the analyses were performed using SPSS software (version 12.0.0, SPSS Inc., Chicago, IL).
Results
Among the 1,840 older adults with complete assessments of baseline and follow-up skeletal muscle mass and strength test, 305 (16.6%) had type 2 diabetes at baseline. Older adults with type 2 diabetes were more likely to be men, black and have lower level of education (Table 1) . Those with diabetes had greater body weight, body mass index, total fat mass as well as higher total lean mass than non-diabetic counterpart. As expected, combined chronic conditions such as coronary heart disease, peripheral artery disease, impaired vision and renal insufficiency were more prevalent in those with type 2 diabetes. IL-6 and TNF-α levels were significantly higher in older adults with diabetes (Table 1) .
Both diabetic and non-diabetic older adults lost significant amount of initial muscle strength in three years. However, older adults with type 2 diabetes lost their knee extensor strength more rapidly than those without diabetes (p=0.001, Table 2 ). Older adults with type 2 diabetes also lost greater amount of leg lean mass than those without diabetes (p<0.05). Furthermore, muscle quality (maximal strength per unit muscle mass, Nm/kg) declined more rapidly in older adults with type 2 diabetes (p<0.05). When expressed in relative changes, older adults with type 2 diabetes showed about 50 % more rapid declines in knee extensor strength (-9.0 % vs. -13.5 %, p=0.002) and muscle quality (-6.2 % vs. -10.0 %, p=0.01) in three years than those without diabetes. However, the changes in hand grip strength and arm muscle quality were not different between those with and without diabetes although older adults with diabetes lost greater amount of arm muscle mass (Table 2 ). There was no indication of interaction effect (p<0.10) of sex or race with diabetes on the changes in muscle strength or muscle quality. Table 3 
and 4).
A greater decline of leg muscle quality in older adults with type 2 diabetes was also evident even after adjustments for demographics, body mass index, baseline muscle quality, changes in leg lean mass, and physical activity (p=0.001, model 2). Further adjustments for combined chronic diseases and inflammatory cytokines attenuated the association of diabetes and declines in muscle quality. However, the greater declines in muscle strength and quality in older adults with type 2 diabetes were remained significant throughout the adjustment models (Table  3) .
Discussion
In this study, older adults with type 2 diabetes lost 13.5 % of their knee extensor strength while those without diabetes lost 9.0 % of initial strength in three years. About 50 % more rapid decline in the knee extensor strength in older adults with diabetes was not accounted for by a greater loss of leg muscle mass. Muscle quality also declined more rapidly in older adults with type 2 diabetes, suggesting that diabetes may result in functional impairments in muscular function of the lower extremities, not necessarily accompanied by loss of muscle mass.
Sarcopenia, a status of decreased skeletal muscle mass, is commonly observed in older adults as a result of age-related loss of muscle mass (17) (18) (19) (20) (21) . In general, it is frequently accompanied by lower skeletal muscle strength. However, determinants or risk factors for sarcopenia and low muscle strength in older adults have not been well identified (22) . This is the first epidemiologic study showing that type 2 diabetes is associated with rapid loss of skeletal muscle mass and strength in older adults. It confirms previous cross sectional finding of lower muscle strength in individuals with diabetes (10) (11) (12) . It is also consistent with the finding of Andreassen, et al. who showed rapid decline of ankle strength in patients with symptomatic diabetic neuropathy (23) . The finding of this longitudinal study strongly suggest that low muscle strength in adults with type 2 diabetes is a consequence rather than just a coincidence with type 2 diabetes.
We found discordance between upper and lower extremities regarding diabetes and changes in muscle strength. A relative preservation of upper extremity strength has been observed in the process of aging (21, 24) . Our findings are, in fact, consistent with previous cross-sectional studies showing decreased skeletal muscle strength at the ankle and knee, but not at the wrist and elbow in patients with type 2 diabetes (10). Andersen et al. reported that upper extremity strength was preserved even in long-standing type 1 diabetic patients (11). They also found that muscle strength was related to the presence and severity of peripheral neuropathy in both type 1 and type 2 diabetic patients (10, 11) . It is well known that lower extremities are predominantly involved in diabetic neuropathy presumably due to a lengthdependent degeneration of nerve fibers (25, 26) . If neuropathy is a factor, skeletal muscle function is more likely to be affected in the lower extremities than in the upper extremities.
The exclusion of many participants for follow-up knee extensor strength test may be potentially biased the results to the null because proportionally more subjects with diabetes were excluded due to high mortality and other reasons (Appendix Table 1 ). We identified 47 participants with diabetes and 181 without diabetes who were excluded from knee strength test but had grip strength test at follow-up examination. Among them, declines in hand grip strength were greater in older adults with diabetes than those without diabetes (-3.3 ± 6.7 vs. -1.1 ± 6.2 kg, p<0.05) suggesting a strict criteria for knee strength testing might select stronger persons and actually obscure the true declines in muscle strength particularly in those with diabetes (Appendix Table 2 ).
Lower extremity strength is essential for maintaining basic physical function, especially mobility such as walking and climbing stairs. It is well known that lower knee extensor strength is associated with increased risk of incident mobility limitations (27) (28) (29) . Although it is unclear whether there is a certain threshold level of leg strength to maintain physical function, lower muscle strength is definitely a risk factor for physical disability independent of lower muscle mass itself (29) .
Several studies suggested that the combination of sarcopenia and obesity, or "sarcopenic obesity" was more strongly associated with disability than either body composition type alone (30, 31) . It is possible that rapid decline in muscle strength in older adults with type 2 diabetes may be associated with sarcopenic obesity. However, to our knowledge there is no study examining the changes in muscle strength in relation to sarcopenic obesity.
The mechanisms for the rapid loss of skeletal muscle strength in older adults with diabetes are not known. Neuropathic processes involving motor neurons could affect muscle strength as evidenced by close association of muscle strength and severity of diabetic neuropathy in the previous cross-sectional observations (10, 11) . Electrophysiologic studies showed that muscle strength in diabetic patients correlated with fiber density and amplitude of the macro motor unit potential, suggesting incomplete reinnervation following axonal loss (32) . Longitudinal studies suggest an average loss of compound muscle action potential amplitude at a rate of ~3% per year in patients with type 2 diabetes over a 10-year period (33) . Unfortunately muscle strength was not assessed in their study. Further research should identify the role of the decrease in motor amplitudes on the skeletal muscle strength and quality in subjects with diabetes.
In our study, adjustments for comorbid conditions such as cardiovascular disease, stroke, congestive heart failure, peripheral arterial disease, depression, impaired vision, and renal insufficiency slightly attenuated the declines in muscle strength. It suggests that chronic complications of diabetes have a limited role for declines in the skeletal muscle strength in older adults with diabetes. However, we had no reliable assessment of nerve function in our study at baseline. It is possible that decline in muscle function may indeed be the result of diabetic neuropathy (23) .
Another potential mechanism could be an increased inflammatory cytokines in subjects with diabetes. It has been reported that systemic inflammatory cytokines such as TNF-α and IL-6 have detrimental effects on muscle mass, strength and physical performance in older adults (34, 35) . In our study, rapid declines in muscle strength and quality in older adults with diabetes are attenuated, albeit still significant, after adjusting for IL-6 and TNF-α. These findings may suggest potential role of inflammatory cytokines on the muscular function in diabetes.
Our study has several limitations. The study participants were well-functioning community-dwelling older adults who were relatively healthier than those in the typical same-aged population. There were many drop-outs and only about 70% of participants were completed follow-up assessments. However, we believe that the lost to follow up may underestimate the true decline in muscle function in those with diabetes (Appendix Table 1 and 2). The questionnaires to assess physical activity in the Health ABC Study have not been validated in the older diabetic subjects. It may not be sensitive enough to detect the influence of different physical activity level on the changes in muscle strength and quality in our study. We also lacked information about neuropathy at baseline, which would be related with muscular function in those with type 2 diabetes.
In conclusion, the present study demonstrates an accelerated loss of knee extensor strength and quality in older adults with type 2 diabetes. Table 2 . Three-year changes in skeletal muscle strength, mass and quality by baseline diabetes status in the Health Aging, and Body Composition study. Table 3 . Adjusted 3-year changes in knee extensor strength and quality by baseline diabetes status in the Health Aging, and Body Composition study.
Appendix Table 1 . Baseline characteristics of those who completed follow-up examination and lost to follow-up examination. Data are mean ± SD, proportions, or median (interquartile range). * P values from age/sex/race-adjusted logistic regression or linear models comparing participants with and without diabetes. † Wilcoxon rank-sum test for comparison of medians. ‡ Subclinical peripheral artery disease was defined as ankle arm index < 0.9. Data are adjusted means ± SE Model 1: adjusted for sex, race, age, and clinic site Model 2: additionally adjusted for body mass index, baseline strength or quality, changes in leg lean mass and physical activity Model 3: additionally adjusted for coronary heart disease, stroke, congestive heart failure, peripheral artery disease, knee osteoarthritis, cancer, depression, impaired vision, renal insufficiency, and subclinical peripheral artery disease (ankle arm index <0.9) Model 4: additionally adjusted for cytokines (log transformed IL-6 and TNF-α)
